Journal of Vascular Surgery
Volume 51, Issue 5 , Pages 1248-1259 , May 2010

Isopropylamine NONOate (IPA/NO) moderates neointimal hyperplasia following vascular injury

  • Nick D. Tsihlis, PhD

      Affiliations

    • Division of Vascular Surgery and Institute for BioNanotechnology in Medicine, Northwestern University, Chicago, Ill
    • ,
  • Jozef Murar, BA

      Affiliations

    • Division of Vascular Surgery and Institute for BioNanotechnology in Medicine, Northwestern University, Chicago, Ill
    • ,
  • Muneera R. Kapadia, MD

      Affiliations

    • Division of Vascular Surgery and Institute for BioNanotechnology in Medicine, Northwestern University, Chicago, Ill
    • ,
  • Sadaf S. Ahanchi, MD

      Affiliations

    • Department of Surgery, University of Illinois at Mt. Sinai, Chicago, Ill
    • ,
  • Christopher S. Oustwani, BA

      Affiliations

    • Division of Vascular Surgery and Institute for BioNanotechnology in Medicine, Northwestern University, Chicago, Ill
    • ,
  • Joseph E. Saavedra, PhD

      Affiliations

    • Basic Research Program, SAIC-Frederick, Inc, Frederick, Md
    • ,
  • Larry K. Keefer, PhD

      Affiliations

    • Laboratory of Comparative Carcinogenesis, NCI at Frederick, Frederick, Md
    • ,
  • Melina R. Kibbe, MD

      Affiliations

    • Division of Vascular Surgery and Institute for BioNanotechnology in Medicine, Northwestern University, Chicago, Ill
    • Jesse Brown Veterans Affairs Medical Center, Chicago, Ill
    • Corresponding Author InformationReprint requests: Melina R. Kibbe, MD, Division of Vascular Surgery and Institute for BioNanotechnology in Medicine, Northwestern University 676 N St Clair, #650, Chicago, IL 60611

Received 31 August 2009 ,Accepted 13 December 2009.

References 

  1. Drago RS, Karstetter BR. The reaction of nitrogen(II) oxide with various primary and secondary amines. J Am Chem Soc. 1961;83:1819–1822
  2. Fukuto JM, Bartberger MD, Dutton AS, Paolocci N, Wink DA, Houk KN. The physiological chemistry and biological activity of nitroxyl (HNO): the neglected, misunderstood, and enigmatic nitrogen oxide. Chem Res Toxicol. 2005;18:790–801
  3. Dutton AS, Suhrada CP, Miranda KM, Wink DA, Fukuto JM, Houk KN. Mechanism of pH-dependent decomposition of monoalkylamine diazeniumdiolates to form HNO and NO, deduced from the model compound methylamine diazeniumdiolate, density functional theory, and CBS-QB3 calculations. Inorg Chem. 2006;45:2448–2456
  4. Bonner FT, Ravid B. Thermal decomposition of oxyhyponitrite (sodium trioxodinitrate(II)) in aqueous solution. Inorg Chem. 1975;14:558–563
  5. Hughes MN, Wimbledon PE. The chemistry of trioxodinitrates (1. Decomposition of sodium trioxdinitrate (Angeli's salt) in aqueous solution). J Chem Soc Dalton Trans. 1976;8:703–707
  6. Paolocci N, Katori T, Champion HC, St JM, Miranda KM, Fukuto JM, et al. Positive inotropic and lusitropic effects of HNO/NO- in failing hearts: independence from beta-adrenergic signaling. Proc Natl Acad Sci U S A. 2003;100:5537–5542
  7. Fukuto JM, Chiang K, Hszieh R, Wong P, Chaudhuri G. The pharmacological activity of nitroxyl: a potent vasodilator with activity similar to nitric oxide and/or endothelium-derived relaxing factor. J Pharmacol Exp Ther. 1992;263:546–551
  8. Arnelle DR, Stamler JS. NO+, NO, and NO− donation by S-nitrosothiols: implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation. Arch Biochem Biophys. 1995;318:279–285
  9. Wong PS, Hyun J, Fukuto JM, Shirota FN, DeMaster EG, Shoeman DW, et al. Reaction between S-nitrosothiols and thiols: generation of nitroxyl (HNO) and subsequent chemistry. Biochemistry. 1998;37:5362–5371
  10. Irvine JC, Favaloro JL, Widdop RE, Kemp-Harper BK. Nitroxyl anion donor, Angeli's salt, does not develop tolerance in rat isolated aortae. Hypertension. 2007;49:885–892
  11. Tocchetti CG, Wang W, Froehlich JP, Huke S, Aon MA, Wilson GM, et al. Nitroxyl improves cellular heart function by directly enhancing cardiac sarcoplasmic reticulum Ca2+ cycling. Circ Res. 2007;100:96–104
  12. Feelisch M. Nitroxyl gets to the heart of the matter. Proc Natl Acad Sci U S A. 2003;100:4978–4980
  13. Yu SM, Hung LM, Lin CC. cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway. Circulation. 1997;95:1269–1277
  14. Kibbe MR, Li J, Nie S, Watkins SC, Lizonova A, Kovesdi I, et al. Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate. J Vasc Surg. 2000;31:1214–1228
  15. Maragos CM, Morley D, Wink DA, Dunams TM, Saavedra JE, Hoffman A, et al. Complexes of .NO with nucleophiles as agents for the controlled biological release of nitric oxide (Vasorelaxant effects). J Med Chem. 1991;34:3242–3247
  16. Ahanchi SS, Varu VN, Tsihlis ND, Martinez J, Pearce CG, Kapadia MR, et al. Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome. Am J Physiol Heart Circ Physiol. 2008;295:H2388–H2398
  17. Kapadia MR, Chow LW, Tsihlis ND, Ahanchi SS, Eng JW, Murar J, et al. Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia. J Vasc Surg. 2008;47:173–182
  18. Han J, Talorete TP, Yamada P, Isoda H. Anti-proliferative and apoptotic effects of oleuropein and hydroxytyrosol on human breast cancer MCF-7 cells. Cytotechnology. 2009;59:45–53
  19. Kibbe MR, Nie S, Seol DW, Kovesdi I, Lizonova A, Makaroun M, et al. Nitric oxide prevents p21 degradation with the ubiquitin-proteasome pathway in vascular smooth muscle cells. J Vasc Surg. 2000;31:364–374
  20. Pearce CG, Najjar SF, Kapadia MR, Murar J, Eng J, Lyle B, et al. Beneficial effect of a short-acting NO donor for the prevention of neointimal hyperplasia. Free Radic Biol Med. 2008;44:73–81
  21. Shears LL, Kibbe MR, Murdock AD, Billiar TR, Lizonova A, Kovesdi I, et al. Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo. J Am Coll Surg. 1998;187:295–306
  22. Shafirovich V, Lymar SV. Nitroxyl and its anion in aqueous solutions: spin states, protic equilibria, and reactivities toward oxygen and nitric oxide. Proc Natl Acad Sci U S A. 2002;99:7340–7345
  23. Miranda KM, Katori T, Torres de Holding CL, Thomas L, Ridnour LA, McLendon WJ, et al. Comparison of the NO and HNO donating properties of diazeniumdiolates: primary amine adducts release HNO in vivo. J Med Chem. 2005;48:8220–8228
  24. Paolocci N, Saavedra WF, Miranda KM, Martignani C, Isoda T, Hare JM, et al. Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling. Proc Natl Acad Sci U S A. 2001;98:10463–10468
  25. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1774–1777
  26. Guo JP, Panday MM, Consigny PM, Lefer AM. Mechanisms of vascular preservation by a novel NO donor following rat carotid artery intimal injury. Am J Physiol. 1995;269:H1122–H1131
  27. Nishio E, Fukushima K, Shiozaki M, Watanabe Y. Nitric oxide donor SNAP induces apoptosis in smooth muscle cells through cGMP-independent mechanism. Biochem Biophys Res Commun. 1996;221:163–168
  28. Iwashina M, Shichiri M, Marumo F, Hirata Y. Transfection of inducible nitric oxide synthase gene causes apoptosis in vascular smooth muscle cells. Circulation. 1998;98:1212–1218
  29. Sarkar R, Gordon D, Stanley JC, Webb RC. Cell cycle effects of nitric oxide on vascular smooth muscle cells. Am J Physiol. 1997;272:H1810–H1818
  30. Sato J, Nair K, Hiddinga J, Eberhardt NL, Fitzpatrick LA, Katusic ZS, et al. eNOS gene transfer to vascular smooth muscle cells inhibits cell proliferation via upregulation of p27 and p21 and not apoptosis. Cardiovasc Res. 2000;47:697–706
  31. Bayes-Genis A, Campbell JH, Carlson PJ, Holmes DR, Schwartz RS. Macrophages, myofibroblasts and neointimal hyperplasia after coronary artery injury and repair. Atherosclerosis. 2002;163:89–98
  32. Pollman MJ, Hall JL, Gibbons GH. Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury (Influence of redox state and cell phenotype). Circ Res. 1999;84:113–121
  33. Shi Y, O'Brien JE, Fard A, Mannion JD, Wang D, Zalewski A. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation. 1996;94:1655–1664
  34. Wink DA, Feelisch M, Fukuto J, Chistodoulou D, Jourd'heuil D, Grisham MB, et al. The cytotoxicity of nitroxyl: possible implications for the pathophysiological role of NO. Arch Biochem Biophys. 1998;351:66–74
  35. Ragsdale RO, Karstetter BR, Drago RS. Decomposition of the adducts of diethylamine and isopropylamine with nitrogen(II) oxide. Inorg Chem. 1965;4:420–422
  36. Spaulding C, Daemen J, Boersma E, Cutlip DE, Serruys PW. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007;356:989–997
  37. Lagerqvist B, James SK, Stenestrand U, Lindback J, Nilsson T, Wallentin L. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med. 2007;356:1009–1019

 This work was supported by the National Institutes of Health (1K08HL084203 to M.R.K.), the American Vascular Association (to M.R.K.), Department of Veterans Affairs (Merit Review Grant to M.R.K.), Mrs Hilda Rosenbloom (to M.R.K.), Ms Eleanor Baldwin (to M.R.K.), the National Cancer Institute, National Institutes of Health with SAIC-Frederick, Inc (Contract NO1-CO-12400 to J.E.S.), and the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research (to L.K.K.).

 Competition of interest: none.

 The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a competition of interest.

PII: S0741-5214(09)02577-4

doi: 10.1016/j.jvs.2009.12.028

Journal of Vascular Surgery
Volume 51, Issue 5 , Pages 1248-1259 , May 2010

Article Tools

* Image Usage & Resolution